Apt Pharmaceuticals

Development for drugs for treatment of lung diseases

placeBurlingame, California, United States calendar_todayFounded 2005 language aptbio.com

Registered entities

Innovation

6 patent families (3 granted) — focus: Human necessities; filing pace dormant. Cited 76 times.

YearFilings
20121

Investor mix

8 investors on record; lead investors include Three Arch Partners.

Investor typeCountShare
Venture capital563%
Private equity225%
Bank & private debt113%
Coming soon